KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$77.2 million.

  • Cme's Change in Accured Expenses fell 38592.59% to -$77.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.8 million, marking a year-over-year increase of 7737.64%. This contributed to the annual value of -$705.9 million for FY2024, which is 20983.35% down from last year.
  • As of Q3 2025, Cme's Change in Accured Expenses stood at -$77.2 million, which was down 38592.59% from $125.0 million recorded in Q2 2025.
  • Over the past 5 years, Cme's Change in Accured Expenses peaked at $586.2 million during Q4 2023, and registered a low of -$605.3 million during Q1 2024.
  • Its 5-year average for Change in Accured Expenses is $4.1 million, with a median of -$14.7 million in 2022.
  • Per our database at Business Quant, Cme's Change in Accured Expenses soared by 70408.16% in 2021 and then plummeted by 62585.03% in 2023.
  • Over the past 5 years, Cme's Change in Accured Expenses (Quarter) stood at $88.8 million in 2021, then soared by 67.68% to $148.9 million in 2022, then skyrocketed by 293.69% to $586.2 million in 2023, then crashed by 102.47% to -$14.5 million in 2024, then tumbled by 432.41% to -$77.2 million in 2025.
  • Its Change in Accured Expenses was -$77.2 million in Q3 2025, compared to $125.0 million in Q2 2025 and -$57.1 million in Q1 2025.